Cencora, Inc. (COR)
$330.11+1.55%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $64.2B
- Beta
- 0.58
- Div yield
- 0.73%
- P/E (TTM)
- 24.42
- Short % float
- 2.13%
- Days to cover
- 2.9
- SI change
- -9.1%
- 1W
- +4.34%
- 1M
- +1.19%
- vs SPY 1W
- +4.48%
- vs SPY 1M
- -1.32%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 60
- VALUE
- 35
- GROWTH
- 31
- GARP
- 53
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC63.9%
REV YoY-
ROE106.4%
EPS YoY-
ROA3.1%
GROSS4
OP1
NET1
[VALUATION]
P/E TTM24.42
P/E FWD18.91
SECTOR PE20.34
INDUSTRY PE14.26
P/B20.90
P/FCF-
EV/EBITDA14.20
EV/EBIT-
PEG1.81
FCF YIELD-
RISK
INT COV-
D/E384.25
ALTMAN Z-
CURR RATIO0.93
ND/EBITDA-
BETA0.58
Company news
FAQ
- What is LOPJLB’s current signal on COR?
- LOPJLB’s latest quantitative signal on Cencora, Inc. (COR) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is COR in?
- Cencora, Inc. (COR) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Cencora, Inc. (COR) do?
- Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment…